We are live on ! Find out more
CFA

Carroll Financial Associates Portfolio holdings

AUM $1.88B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+20.52%
3 Year Est. Return
+80.57%
5 Year Est. Return
+102.34%
10 Year Est. Return
AUM
$1.26B
AUM Growth
+$114M
Cap. Flow
+$39.5M
Cap. Flow %
3.14%
Top 10 Hldgs %
49.48%
Holding
1,801
New
113
Increased
378
Reduced
335
Closed
105
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBUX icon
201
Starbucks
SBUX
$120B
$574K 0.05%
6,529
-2
-0% -$171
IHI icon
202
iShares US Medical Devices ETF
IHI
$3.38B
$570K 0.05%
12,954
-594
-4% -$25K
CVS icon
203
CVS Health
CVS
$122B
$566K 0.05%
7,627
+365
+5% +$25.6K
MDLZ icon
204
Mondelez International
MDLZ
$79.9B
$561K 0.04%
10,189
+847
+9% +$45.3K
KMI icon
205
Kinder Morgan
KMI
$68.7B
$560K 0.04%
26,470
+83
+0.3% +$1.68K
CTVA icon
206
Corteva
CTVA
$51.3B
$550K 0.04%
18,633
-1,305
-7% -$34.6K
BABA icon
207
Alibaba
BABA
$308B
$542K 0.04%
2,560
+291
+13% +$54.6K
AHRT
208
AH Realty Trust
AHRT
$517M
$539K 0.04%
29,387
+1
+0% +$18
SNA icon
209
Snap-on
SNA
$21.5B
$517K 0.04%
3,056
VOO icon
210
Vanguard S&P 500 ETF
VOO
$1.01T
$517K 0.04%
1,749
+258
+17% +$73K
VXUS icon
211
Vanguard Total International Stock ETF
VXUS
$160B
$514K 0.04%
9,233
+6,190
+203% +$333K
NVS icon
212
Novartis
NVS
$297B
$504K 0.04%
5,324
+784
+17% +$70.3K
NVDA icon
213
NVIDIA
NVDA
$5.42T
$502K 0.04%
85,360
+10,760
+14% +$56K
IBB icon
214
iShares Biotechnology ETF
IBB
$9.77B
$501K 0.04%
4,160
-250
-6% -$27.9K
GPC icon
215
Genuine Parts
GPC
$18.7B
$498K 0.04%
4,690
+51
+1% +$5.24K
PPG icon
216
PPG Industries
PPG
$26.6B
$494K 0.04%
3,707
+164
+5% +$20.8K
GIS icon
217
General Mills
GIS
$19.7B
$493K 0.04%
9,219
+388
+4% +$20.4K
PFM icon
218
Invesco Dividend Achievers ETF
PFM
$808M
$489K 0.04%
15,924
+920
+6% +$27.5K
IWM icon
219
iShares Russell 2000 ETF
IWM
$83B
$488K 0.04%
2,947
-43
-1% -$6.8K
AEP icon
220
American Electric Power
AEP
$68.4B
$480K 0.04%
5,087
-105
-2% -$9.7K
IYC icon
221
iShares US Consumer Discretionary ETF
IYC
$1.23B
$480K 0.04%
8,416
-456
-5% -$25.3K
VCIT icon
222
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
$480K 0.04%
5,261
+18
+0.3% +$1.64K
QAI icon
223
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.02B
$479K 0.04%
+15,564
New +$480K
VB icon
224
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$478K 0.04%
2,886
+9
+0.3% +$1.43K
TSM icon
225
TSMC
TSM
$2.18T
$474K 0.04%
8,164
-1,238
-13% -$65.7K

Similar funds

Carroll Financial Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Carroll Financial Associates held 1,801 positions worth $1.26B, up 9.9% from $1.14B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Carroll Financial Associates deployed $39.5M of net new capital in Q4 2019, opening 113 new positions and adding to 378 existing holdings. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 46,097 shares worth $2.52M.

By sector, the portfolio is most concentrated in Financials at 6.8% of assets, down from 6.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares 3-7 Year Treasury Bond ETF, an estimated $11.3M trimmed.

  • Carroll Financial Associates's largest Q4 2019 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 46,097 shares worth $2.52M.
  • Carroll Financial Associates added most to Global X Adaptive US Factor ETF in Q4 2019, an estimated $21.1M increase.
  • Carroll Financial Associates's biggest Q4 2019 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $11.3M.
  • Carroll Financial Associates fully exited State Street DoubleLine Total Return Tactical ETF in Q4 2019, selling an estimated $1.17M.
  • Carroll Financial Associates's ten largest holdings make up 49% of its $1.26B portfolio in Q4 2019.
  • Carroll Financial Associates opened 113 new positions and closed 105 in Q4 2019.
  • Carroll Financial Associates's portfolio value rose 9.9% quarter-over-quarter to $1.26B.

Based on Carroll Financial Associates's 13F filing for Q4 2019, filed 8 Jan 2020.